The Deoxypyridinoline (DPD) test is primarily used to assess bone resorption, particularly in conditions such as osteoporosis, Paget's disease of bone, and other disorders related to altered bone metabolism. It helps monitor the effectiveness of osteoporosis treatment, evaluate fracture risk, and support the diagnosis of bone resorption disorders